Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This study investigates the interactions between certain types of heparins and a specific enzyme produced by white blood cells, uncovering how these relate to the condition of equine laminitis. Findings suggest that both types of heparins reduced the activity of the enzyme, potentially shedding light on their anti-inflammatory properties and their role in preventing laminitis.
Understanding the Research
The researchers aimed to understand the interplay among heparins, a chemical (myeloperoxidase or MPO) produced by certain white blood cells, and laminitis in horses, specifically:
- They first examined how unfractionated heparins (UFH) and low molecular weight heparins (LMWH), both of which are anti-coagulant drugs used to treat and prevent blood clots, affected the activity of Myeloperoxidase (MPO), an enzyme found in neutrophils (a type of white blood cell).
- A closer look was taken at how both types of heparins affected the interaction between MPO and endothelial cells, which line the interior surface of blood vessels, from horses’ hooves (both arterial and venous).
- The heparins’ effects on MPO activity were tested using a process of immunocapture, which involved capturing MPO with antibodies, followed by detection of enzymatic activity.
Key Findings
The important findings from the study included:
- A dose-dependent inhibition of MPO activity was observed with both UFH and LMWH, meaning that higher concentrations of heparin resulted in greater reduction of MPO activity. The greatest reduction was noted with the highest concentration of LMWH.
- MPO was more readily captured by arterial cells, but addition of heparins led to greater reduction in MPO capture in venous cells.
- The heparins almost completely suppressed the activity of MPO that was bound to cells, with no significant differences observed between UFH and LMWH.
Implications of the Research
The researchers suggested that the findings confirm the anti-inflammatory properties of heparins, owing to their reduction of MPO activity, attributed to an inflammatory response. As such, this research helps build a better understanding of the potential role of MPO in the development of equine laminitis, an inflammation of tissues within the hoof of the horse, and affirms heparins’ potential for prevention of this debilitating condition.
Cite This Article
Publication
Researcher Affiliations
- Department of Clinical Sciences, Large Animal Surgery, Faculty of Veterinary Medicine B41, University of Liège, Sart Tilman, 4000 Liège, Belgium. G.delaRebieredePouyade@ulg.ac.be
MeSH Terms
- Animals
- Cells, Cultured
- Endothelial Cells / drug effects
- Endothelial Cells / metabolism
- Foot Diseases / physiopathology
- Foot Diseases / veterinary
- Heparin / pharmacology
- Heparin, Low-Molecular-Weight / pharmacology
- Horse Diseases / physiopathology
- Horses
- Peroxidase / metabolism
Citations
This article has been cited 4 times.- Storms N, Medina Torres C, Franck T, Sole Guitart A, de la Rebière G, Serteyn D. Presence of Myeloperoxidase in Lamellar Tissue of Horses Induced by an Euglycemic Hyperinsulinemic Clamp. Front Vet Sci 2022;9:846835.
- Amaral-Machado L, Oliveira WN, Torres-Rêgo M, Furtado AA, Alencar ÉN, Fernandes-Pedrosa MF, Rocha HAO, Egito EST. Anti-Inflammatory Activity of Bullfrog Oil Polymeric Nanocapsules: From the Design to Preclinical Trials. Int J Nanomedicine 2021;16:7353-7367.
- de Rebière de Pouyade G, Salciccia A, Ceusters J, Deby-Dupont G, Serteyn D, Mouithys-Mickalad A. Production of free radicals and oxygen consumption by primary equine endothelial cells during anoxia-reoxygenation. Open Biochem J 2011;5:52-9.
- Finding EJT, Faulkner A, Nash L, Wheeler-Jones CPD. Equine Endothelial Cells Show Pro-Angiogenic Behaviours in Response to Fibroblast Growth Factor 2 but Not Vascular Endothelial Growth Factor A. Int J Mol Sci 2024 May 30;25(11).